LOGC

LogicBio Therapeutics, Inc. Common Stock

Delisted

LOGC was delisted on the 15th of November, 2022.

33 hedge funds and large institutions have $124M invested in LogicBio Therapeutics, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
33
Holders Change
-3
Holders Change %
-8.33%
% of All Funds
0.72%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
3
Increased
10
Reduced
8
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
SO
26
STRS Ohio
Ohio
$21K
Citigroup
27
Citigroup
New York
$21K +$16.1K +1,600 +327%
JPMorgan Chase & Co
28
JPMorgan Chase & Co
New York
$20K -$4.67K -463 -19%
Morgan Stanley
29
Morgan Stanley
New York
$14K -$107K -10,985 -88%
Legal & General Group
30
Legal & General Group
United Kingdom
$12K
AIP
31
Ameritas Investment Partners
Nebraska
$7K
TRCT
32
Tower Research Capital (TRC)
New York
$6K +$6K +609 New
Goldman Sachs
33
Goldman Sachs
New York
-$675K -64,949 Closed
LCM
34
Landscape Capital Management
New Jersey
-$578K -55,597 Closed
DIM
35
DC Investments Management
Virginia
-$543K -52,174 Closed
LCM
36
Laurion Capital Management
New York
-$156K -15,000 Closed
Susquehanna International Group
37
Susquehanna International Group
Pennsylvania
-$146K -14,068 Closed
CCA
38
Catalyst Capital Advisors
New York
-$6K -620 Closed